Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
23%(3 trials)

Phase Distribution

Ph phase_1
2
13%
Ph not_applicable
8
50%
Ph phase_4
4
25%

Phase Distribution

2

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 4Post-market surveillance
4(28.6%)
N/ANon-phased studies
8(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(13)
Terminated(2)

Detailed Status

Completed13
Withdrawn2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 44 (28.6%)
N/A8 (57.1%)

Trials by Status

withdrawn213%
completed1381%
not_yet_recruiting16%

Recent Activity

0 active trials
Showing 5 of 16
completed

Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment

NCT06819046
not_yet_recruitingphase_1

Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.

NCT06379685
completedphase_4

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)

NCT03223909
completedphase_1

Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects

NCT03524157
completednot_applicable

Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops

NCT03706443
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06819046

Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment

Completed
NCT06379685Phase 1

Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.

Not Yet Recruiting
NCT03223909Phase 4

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)

Completed
NCT03524157Phase 1

Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects

Completed
NCT03706443Not Applicable

Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops

Completed
NCT03183089Phase 4

Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye

Completed
NCT00812721Not Applicable

Tears Substitutions and Their Effects on Higher Order Aberrometery

Withdrawn
NCT00946777Not Applicable

Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days

Completed
NCT02558218Not Applicable

Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery

Completed
NCT01775540Not Applicable

Systane Ultra Versus Maxidex Versus Saline

Completed
NCT00781092Phase 4

A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes

Completed
NCT00938951Not Applicable

Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

Completed
NCT01417013Not Applicable

Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time

Withdrawn
NCT00702377Not Applicable

Evaluation of SYSTANE Ultra Lubricant Eye Drops

Completed
NCT01051804Phase 4

Evaluation of the Repeated Usage of Systane Ultra Eyedrop

Completed
NCT00769665

A 2-week Clinical Comparison of SYSTANE® Ultra to Sensitive Eyes Rewetting Drops in Contact Lens Wearing Patients.

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16